Home
/
Blog
/
What Is Retatrutide vs Tirzepatide?

What Is Retatrutide vs Tirzepatide?

Navin Khosla NowPatientGreen tick
Medically reviewed by Navin Khosla, B.Pharm
Written by

Created
April 2, 2025 (Current Version)

In recent years, the landscape for obesity treatment has been rapidly evolving and two medications retatrutide and tirzepatide have gained considerable attention for their weight loss results. While both drugs leverage the body’s natural hormone-based regulation of energy homeostasis, it is crucial to distinguish these two therapies.

📝 Understanding tirzepatide

Tirzepatide, known by the brand names Mounjaro and Zepbound, is a groundbreaking medication for the management of type 2 diabetes and weight loss. As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, it offers a novel approach to treatment:

Mechanism of action

Tirzepatide effectively stimulates insulin release from the pancreas, which helps to reduce hyperglycemia. It also increases adiponectin levels, which can play a role in decreasing insulin resistance. The drug’s dual action as a GIP and GLP-1 receptor agonist aids in decreasing appetite and slowing food movement from the stomach, which can lead to weight loss.

Dosage and administration

Available in various dosage forms, including subcutaneous solutions and injections, tirzepatide offers flexibility with strengths ranging from 2.5 mg to 15 mg. The recommended maintenance dosages are 5 mg, 10 mg, or 15 mg once weekly, which caters for individual patient needs.

Efficacy and safety

Beyond its primary use for type 2 diabetes, tirzepatide has been explored for its potential in treating obesity, osteoarthritis of the knee, atherosclerosis, and other metabolic diseases. The SURPASS clinical trials have highlighted its significant A1C lowering and weight loss benefits, marking it as a promising option for patients with diabetes and obesity.

It is important to note that tirzepatide comes with a boxed warning for the risk of thyroid C-cell tumors, and may delay gastric emptying, which could affect the oral absorption of other medications. As a prescription-only medication, healthcare providers need to consider each patient’s unique circumstances when prescribing tirzepatide for diabetes or weight management.

📝 Introducing retatrutide

Retatrutide is a new medication that targets the glucose-dependent insulinotropic polypeptide (GIP receptor), glucagon-like peptide-1 (GLP-1), and glucagon receptors (GCG receptors). This unique mechanism of action sets retatrutide apart from traditional weight loss drugs such as semaglutide (Wegovy) as it aims to target all three of these key hormones involved in glucose (blood sugar levels) and satiety regulation.

Mechanism of action

Retatrutide activates the GIP, GLP-1, and GCG receptors simultaneously, which may lead to better weight loss and cardiometabolic benefits compared to targeting a single receptor. GIP is involved in glucose and lipid metabolism, GLP-1 regulates insulin secretion and appetite, and GCG plays a role in energy expenditure and substrate utilisation.

Dosing and administration

Retatrutide is administered subcutaneously once weekly, with dosing regimens ranging from 1 mg to 12 mg. For higher doses (4 mg and above), the medication is typically started at a lower dose (2 mg or 4 mg) and gradually built up to reduce the potential for gastrointestinal side effects.

Efficacy and safety

In clinical trials, patients taking retatrutide have shown an average weight loss reduction of up to 24% from baseline body weight. The medication has also been associated with improvements in various cardiometabolic parameters, including blood pressure, glycemic control, and lipid profiles. While retatrutide shares some common side effects with GLP-1 receptor agonists, such as gastrointestinal events, the frequency and severity of these adverse events appear to be dose-dependent and can be reduced by the use of a lower starting doses of retatrutide.

🗝️ Key differences between tirzepatide and retatrutide

Retatrutide vs Tirzepatide

The primary distinction between retatrutide and tirzepatide lies in their mechanism of action. Tirzepatide is a dual agonist, targeting the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, while retatrutide is a triple agonist, targeting GIP, GLP-1, and GCG simultaneously. This difference in receptor activation may contribute to the variations in weight loss and cardiometabolic outcomes between the two medications.

Magnitude of weight loss

Phase 2 clinical trial results published in The New England journal of medicine suggest retatrutide may prompt even greater weight loss than other weight-loss medications, including Zepbound. The weight-loss results at 48-weeks found with the 12 mg retatrutide group an average weight reduction of 24.2% was achieved, while the placebo group only saw a 2.1% change. In contrast, Clinical trials have shown that on average, patients lost up to 22.5% of their original weight on the highest dose of Mounjaro (15mg) after 72 weeks.

Cardiometabolic benefits

Both tirzepatide and retatrutide have demonstrated improvements in various cardiometabolic risk factors, such as blood pressure, lipid profiles, and glycemic control. However, the triple-hormone receptor agonism of retatrutide may bring additional benefits, potentially leading to more improvements in these parameters.

Safety and tolerability

While both medications share common side effects, such as gastrointestinal issues, and constipation. The frequency and severity of these events may differ. Retatrutide has shown a dose-dependent profile, with higher doses associated with a higher incidence of gastrointestinal events. The use of a lower starting dose for retatrutide can be a way to reduce these side effects.

It’s important to consult with a healthcare professional for guidance on how to manage any discomfort and to understand what to expect when starting the medication.

FDA approval

The U.S. Food and Drug Administration approved tirzepatide weekly injections for chronic weight management in adults who are overweight or have obesity, with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol), in addition to a reduced calorie diet and increased physical activity in November 2023.

Retatrutide is a weight loss drug that has not yet received approval from the U.S. Food and Drug Administration (FDA) for the treatment of obesity. The compound is currently in the development pipeline, with Eli Lilly, the pharmaceutical company behind its creation, actively pursuing the next stages of the regulatory process. 2026 will be the earliest possible date doctors can prescribe retatrutide, assuming that the drug passes later-stage human trials now underway.

Personalised approach to weight management

As with any medical intervention, the response to weight loss medications can vary among individuals. Understanding the factors that influence an individual’s response, such as baseline BMI, sex, and comorbidities, will be crucial in guiding the selection of the most appropriate treatment approach.

Research and future developments

The promising results from the phase 2 trial of retatrutide have paved the way for further investigation in larger, phase 3 clinical trials. These studies will provide valuable insights into the long-term efficacy, safety, and tolerability of this triple-hormone receptor agonist, as well as its potential impact on cardiovascular outcomes.

📝 Conclusion

As the obesity epidemic continues to be a significant global health challenge, new weight loss drugs like retatrutide represent a significant advancement in the field of obesity management. While tirzepatide and retatrutide share the common goal of weight loss and improving metabolic health, the unique triple-hormone receptor agonism of retatrutide sets it apart, offering the potential for more significant weight loss and sustained weight reduction.

Sources

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Now Patient Data Security

Trusted and Certified to Keep Your Data Safe.

Learn moreNow Patient Data Security
Now Patient Data Security

Can I Trust NowPatient

Certified to International Healthcare, Medical Device and Data Security Standards

  • DCB0129 compliance logo
  • DCB0160 compliance-logo
  • DCB3051 compliance logo
  • DTAC certified logo
  • UKCA logo
  • NHS Providing services logo
  • Data security standards exceeded logo
  • NHS digital logo
  • Cyber Essentials logo
  • Cyber essentials plus logo
  • Registered pharmacy 1036487 logo
  • Hipaa compliant logo
  • ISO 27001 logo
  • GDPR Logo
  • ISO 9001 certified logo
  • ISO 13485 certified logo
  • ISO 27001 certified logo
  • Class 1 Medical Device
  • City St George's University of London logo
  • Innovate UK logo

Medicines Experts

Meet Our Medical Team

We are a broad skilled and passionate group of clinicians with experience of operating in health systems in the United Kingdom & United States. Providing excellent care and advice is at the heart of everything we do. You can read more about our medical team by visiting the medical team page or learn more about how we curate content by visiting our editorial process

WHY WE BUILT NOWPATIENT

We Are Committed to Helping Everyone, Everywhere Live Healthier Lives

The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.

Download our app today

NowPatient app on a mobile device

Your Questions Answered

For Your Peace of Mind, We Can Answer Your Questions Quickly

What does NowPatient do?

NowPatient is a digital health-technology platform functioning as both an online pharmacy and telehealth service. Packaged as a Class I software medical device, it’s accessible via web browser or mobile app (iOS and Android), and offers users worldwide on-demand access to virtual consultations, prescription services, and AI-powered health tools.

What It Does

    • NHS Online Pharmacy: Order NHS-approved prescriptions (UK)
    • Drug Savings: Access major US drug-savings programs (coupons, savings cards, manufacturer assistance, Canadian drug savings).
    • Virtual Consultations: Get treated for a wide range of medical conditions by expert clinicians using a secure telehealth link.
    • Medication Management: Set up refill & dose reminders, view private treatment plans, and track chronic conditions like diabetes or hypertension.
  • Health-Monitoring Tools: Use AI-driven assessments for genetic risk tests, home test kits and blood-pressure monitoring.
  • Wellness Insights: Access real-time pollen counts, air-quality data, BMI and type 2 diabetes risk scores, plus comprehensive health-condition information.

Get started today and benefit from Medication RemindersGet Treated PrivatelyNHS Online PharmacyGP Appointment BookingRx Savings CardDrug CouponsUS Drug Savings ProgramsHealth Conditions InformationGenetic TestingHome Test KitsBMI RisksType 2 Diabetes RisksPollen MeterAir Quality Monitor, and lots more!

Our service is operated by experienced medical professionals in the United States and the United Kingdom.

Where is NowPatient located?

NowPatient has offices in the United Kingdom and United States.

In the UK, we are located at:

NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA

In the US, we are located at:

NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX

How can I contact NowPatient?

To contact NowPatient, please use the contact form available on the Contact Us page.

Alternatively, if you need to speak to us, you can reach us on the following numbers:

UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977

Who owns NowPatient?

NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.

Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).

Can you tell me more about your NHS online pharmacy?

NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.

Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).

Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.

How do I make a complaint?

From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.

Can you tell me more about NowPatient’s prescribing services for treatments offered?

Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:

• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old

NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla. Dr Ihtesham Sabri is the Medical Director for NowPatient and is responsible for NowPatient’s prescribing formulary and treatment guidelines, which are used by clinicians for safe and effective prescribing.

Can you tell me more about NowPatient’s US services?

Our head of US services is Dr. Jamie Winn.

You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.

What are the steps to booking a live video consultation?

Follow the steps below to book a consultation:

How to Book a Consultation With NowPatient
  • Book gp consultation slideshow 1
    1
    Book Consultation
  • Book gp consultation slideshow 2
    2
    Choose Consultation Date
    Next, you’ll be taken to the ‘Consultation Date’ screen, where you can select your preferred consultation date. You can also add any notes that might assist the clinician during your session. Click ‘Continue’ to proceed.
  • Book gp consultation slideshow 3
    3
    Choose Consultation Time
    You will now see the ‘Consultation Time’ screen. Select your preferred time for the consultation and then click ‘Continue’.
  • Book gp consultation slideshow 4
    4
    Choose Clinician
    On the ‘Choose Clinician’ screen, you’ll be able to view available clinicians and select the one you prefer. You can filter the list by gender and spoken languages. Once you’ve made your selection, click ‘Continue’.
  • Book gp consultation slideshow 5
    5
    Booking Confirmation
    You will now arrive at the ‘Booking Confirmation’ screen, where you can review a summary of your booking. This screen also includes an advisory titled ‘Pre-consultation Requirements’, which offers helpful tips on how to prepare for your live video consultation. Click ‘Continue’ to proceed.
  • Book gp consultation slideshow 6
    6
    Safety Information & Reminders
    You’ll be asked to provide safety information, including: - The address where you will be during the consultation - Emergency contact details You can also opt to receive an SMS reminder 30 minutes before your scheduled video consultation.
  • Book gp consultation slideshow 7
    7
    Final Confirmation
    Click ‘Confirm Booking’ to complete the process. A pop-up will appear to confirm your booking, and you will be redirected to your account homepage. You’ll also receive confirmation via In-App and Push notifications.
scrollable

If I place an order, how do I check out?

Follow the steps below to checkout:

How to Checkout on NowPatient
  • Go to Cart using Account Navigation - order
    1
    Go to Cart using Account Navigation
  • If there is an NHS service item in the Cart - An NHS Exemption Declaration will Pop Up - order
    2
    If there is an NHS service item in the Cart - An NHS Exemption Declaration will Pop Up
  • Complete the NHS Exemption Declaration for each NHS service item - order
    3
    Complete the NHS Exemption Declaration for each NHS service item
  • Select ‘Checkout’ - order
    4
    Select ‘Checkout’
  • Select Delivery Address - order
    5
    Select Delivery Address
  • Select Delivery Method - order
    6
    Select Delivery Method
  • Confirm Billing Address - order
    7
    Confirm Billing Address
  • Review Order - order
    8
    Review Order
  • 9
    Submit Payment
  • Order Completed - order
    10
    Order Completed
  • Return to Account Homepage - order
    11
    Return to Account Homepage
scrollable

Is NowPatient legit and can I trust information from NowPatient?

Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.

NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.

Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:

NowPatient Trustpilot

Does NowPatient have insurance in place for the services it provides?

Yes. NowPatient is fully insured to provide pharmacy & prescribing services. Insurance not only provides peace of mind but also provides an effective safety net for both you and our clinicians.

Why is it important to choose an online pharmacy and telehealth service that is insured?

Insurance is more than just a financial safeguard, it is a signal of legitimacy and accountability.

We insure our services, so that it:

  • Shows you that we are compliant with all laws and industry standards in the markets that we operate.
  • Shows you that we are committed to standards of professionalism.
  • Reinforces your confidence that you are dealing with a reputable provider.

Who insures your services and which services are insured?

We are insured by the National Pharmacy Association in the UK.

The scope of the services covered include:

  • dispensing of prescriptions
  • telehealth prescribing services.

In addition, all of the clinicians that operate on our platform have their personal indemnity insurance & scope of clinical practice validated and checked before they are able to provide services.

What are NowPatient’s opening hours?

Our office hours are:

UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST

Please note that we are closed at weekends.

In the event of a medical life-threatening emergency please call:

UK – 999
US – 911

In the event of a medical emergency which is not life-threatening please call:

UK – 111